DaVita
Preço: 208.66Empresa e modelo de negócios
DaVita Inc. operates in the healthcare sector, primarily providing kidney care and dialysis services. The company offers a range of services including in-center hemodialysis, home dialysis, and related laboratory services. Its major business segments include dialysis services and ancillary services, with the majority of revenue generated from patient services in its dialysis centers. DaVita serves a diverse patient population across the United States and has a growing presence in international markets.
Perfil de investimento
The investment profile of DaVita is more aligned with growth investors, given its focus on expanding services and improving patient care. The company has shown potential for revenue growth despite recent fluctuations. It may appeal to investors looking for a balanced approach, considering its operational stability and market position.
Métricas fundamentais (experimental)
- EPS (TTM) — lucro por ação dos últimos 12 meses, $
- 10.15 OK
- Receita QoQ — crescimento da receita trimestre contra trimestre
- -5.6% ↓
- Surpresa de EPS
- 23.2% melhor que o esperado
- Volatilidade 20d
- 1.9% estável
Acompanhar no portfólio
Gráfico de preço
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-06-10 00:47 | Manter | Comprar | Strong momentum and positive EPS surprise support growth outlook. |
| 2026-06-01 02:36 | Comprar | Manter | Strong momentum but recent revenue decline raises concerns. |
| 2026-05-16 02:40 | Manter | Comprar | Strong momentum and positive EPS surprise support bullish outlook. |
| Data | Analista | Action | Alvo | Preço na época |
|---|---|---|---|---|
| 2026-05-08 11:56 | Truist Financial | Preço-alvo elevado | 158 → 205 | 194.385 |
| 2026-05-07 09:46 | Barclays | Preço-alvo elevado | 158 → 194 | 193.88 |
| 2026-05-06 08:37 | Deutsche Bank | Rating elevado | — → 220 | 157.04 |
Nada ainda